About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: March 22, 2007
Revising Advisory Committee Criteria
The FDA has issued a new draft guidance on Advisory Committee criteria in an attempt to quell the rising tide of criticism that advisory committee members are often too tied to industry to be rendering impartial decisions. The outline of … Continue reading
Posted in FDA Image, FDA Policy
Comments Off on Revising Advisory Committee Criteria